BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 33080526)

  • 1. Long noncoding RNAs (lncRNAs) in cervical carcinogenesis: New molecular targets, current prospects.
    Galvão MLTC; Coimbra EC
    Crit Rev Oncol Hematol; 2020 Dec; 156():103111. PubMed ID: 33080526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive analysis of lncRNAs microarray profile and mRNA-lncRNA co-expression in oncogenic HPV-positive cervical cancer cell lines.
    Yang L; Yi K; Wang H; Zhao Y; Xi M
    Oncotarget; 2016 Aug; 7(31):49917-49929. PubMed ID: 27363024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long noncoding RNAs in cervical cancer.
    Shi D; Zhang C; Liu X
    J Cancer Res Ther; 2018; 14(4):745-753. PubMed ID: 29970647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic gene microarray analysis of the lncRNA expression profiles in human uterine cervix carcinoma.
    Chen J; Fu Z; Ji C; Gu P; Xu P; Yu N; Kan Y; Wu X; Shen R; Shen Y
    Biomed Pharmacother; 2015 May; 72():83-90. PubMed ID: 26054679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non-coding RNA in cervical cancer: From biology to therapeutic opportunity.
    He J; Huang B; Zhang K; Liu M; Xu T
    Biomed Pharmacother; 2020 Jul; 127():110209. PubMed ID: 32559848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant expression of long noncoding RNAs in cervical intraepithelial neoplasia.
    Gibb EA; Becker-Santos DD; Enfield KS; Guillaud M; Niekerk Dv; Matisic JP; Macaulay CE; Lam WL
    Int J Gynecol Cancer; 2012 Nov; 22(9):1557-63. PubMed ID: 23095774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long non-coding RNAs as critical regulators and novel targets in cervical cancer: current status and future perspectives.
    Ranga S; Yadav R; Chhabra R; Chauhan MB; Tanwar M; Yadav C; Kadian L; Ahuja P
    Apoptosis; 2023 Aug; 28(7-8):925-942. PubMed ID: 37095313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defining new biomarkers for overcoming therapeutical resistance in cervical cancer using lncRNA.
    Aswathy R; Sumathi S
    Mol Biol Rep; 2023 Dec; 50(12):10445-10460. PubMed ID: 37878205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNAs and cervical cancer.
    Aalijahan H; Ghorbian S
    Exp Mol Pathol; 2019 Feb; 106():7-16. PubMed ID: 30471246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dysregulated expression of long noncoding RNAs in gynecologic cancers.
    Hosseini ES; Meryet-Figuiere M; Sabzalipoor H; Kashani HH; Nikzad H; Asemi Z
    Mol Cancer; 2017 Jun; 16(1):107. PubMed ID: 28637507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNAs: key players and novel insights into cervical cancer.
    Peng L; Yuan X; Jiang B; Tang Z; Li GC
    Tumour Biol; 2016 Mar; 37(3):2779-88. PubMed ID: 26715267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non-coding RNA FAM83H-AS1 is regulated by human papillomavirus 16 E6 independently of p53 in cervical cancer cells.
    Barr JA; Hayes KE; Brownmiller T; Harold AD; Jagannathan R; Lockman PR; Khan S; Martinez I
    Sci Rep; 2019 Mar; 9(1):3662. PubMed ID: 30842470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The transcriptome profiles and methylation status revealed the potential cancer-related lncRNAs in patients with cervical cancer.
    Yuan LY; Qin X; Li L; Zhou J; Zhou M; Li X; Xu Y; Wang XJ; Xing H
    J Cell Physiol; 2019 Jun; 234(6):9756-9763. PubMed ID: 30362566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long noncoding RNA CCHE1 promotes cervical cancer cell proliferation via upregulating PCNA.
    Yang M; Zhai X; Xia B; Wang Y; Lou G
    Tumour Biol; 2015 Sep; 36(10):7615-22. PubMed ID: 25921283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cervical carcinoma high expressed 1 (CCHE1): An oncogenic lncRNA in diverse neoplasms.
    Ghafouri-Fard S; Azimi T; Taheri M
    Biomed Pharmacother; 2021 Oct; 142():112003. PubMed ID: 34385101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypomethylation of the lncRNA SOX21-AS1 has clinical prognostic value in cervical cancer.
    Wang R; Li Y; Du P; Zhang X; Li X; Cheng G
    Life Sci; 2019 Sep; 233():116708. PubMed ID: 31369759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non-coding RNAs on the stage of cervical cancer (Review).
    Dong J; Su M; Chang W; Zhang K; Wu S; Xu T
    Oncol Rep; 2017 Oct; 38(4):1923-1931. PubMed ID: 28849103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roles and Mechanisms of the Long Noncoding RNAs in Cervical Cancer.
    Cáceres-Durán MÁ; Ribeiro-Dos-Santos Â; Vidal AF
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33371204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non-coding RNAs as new players in cervical carcinogenesis: an update.
    Salmerón-Bárcenas EG; Mendoza-Catalán MA; Illades-Aguiar B; Peralta-Arrieta I; Alquisiras-Burgos I; Ortiz-Ortiz J; Navarro-Tito N; Zacapala-Gómez AE
    Eur Rev Med Pharmacol Sci; 2020 Aug; 24(16):8314-8328. PubMed ID: 32894538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human Papillomavirus E6/E7 and Long Noncoding RNA TMPOP2 Mutually Upregulated Gene Expression in Cervical Cancer Cells.
    He H; Liu X; Liu Y; Zhang M; Lai Y; Hao Y; Wang Q; Shi D; Wang N; Luo XG; Ma W; Zhang TC
    J Virol; 2019 Apr; 93(8):. PubMed ID: 30728257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.